Ultrasound-guided high-intensity focused ultrasound treatment for abdominal wall endometriosis: a retrospective study

Sheng‐Dean Luo, Luo S, S Luo, Cai Zhang, C. Zhang, J P Huang, Huang JP, JP Huang, G H Huang, G-H Huang, Huang GH, He J, Jia He, J He
BJOG: An International Journal of Obstetrics & Gynaecology · 2017 · vol. 124(S3) , pp. 59–63 · doi:10.1111/1471-0528.14741 · PMID:28856852 · W2750699795
Other OA: bronze CC0 ⤵ 28 in-corpus citations
🔓 Open OA copy View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-07 ⓘ

Ultrasound-guided high-intensity focused ultrasound effectively ablated abdominal wall endometriosis lesions, significantly reducing lesion volume and pain scores with only temporary local edema and no severe complications.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

OBJECTIVE: To evaluate the safety and efficacy of ultrasound-guided high-intensity focused ultrasound (USgHIFU) for treating abdominal wall endometrioses (AWE). DESIGN: A retrospective study. SETTING: Department of Obstetrics and Gynaecology in China. POPULATION: Patients with abdominal wall endometriosis. METHODS: From August 2010 to April 2014, 32 patients with AWE were treated with USgHIFU in our hospital. USgHIFU treatment was performed with the Model JC-200 High Intensity Focused Ultrasound Tumor Therapeutic System. The symptom relief and the adverse effects were evaluated after USgHIFU ablation. MAIN OUTCOME MEASURES: USgHIFU as a new treatment option for patients with AWE. RESULTS: Contrast-enhanced ultrasound showed that all lesions were successfully ablated with USgHIFU. The follow-up results showed that the average volume of AWE lesions at 6 months after USgHIFU was significantly smaller than that before treatment (2.80 ± 0.12 versus 1.33 ± 0.31 cm3 ). The pain scores at 6 months after treatment were significantly lower than those before treatment (6.80 ± 2.64 versus 1.80 ± 0.3). The non-perfused volume (indicative of successful ablation) was measured in all patients immediately after treatment, ranging from 0.9 to 2.1 cm3 (median: 1.6 cm3 ), and the fractional ablation ranged from 87% to 100% (median: 94%). Local oedema was observed in these patients, lasting for 1-3 days only. No severe complications occurred during the follow-up period. CONCLUSIONS: Based on our study, USgHIFU ablation is a safe and effective method for treating AWE. TWEETABLE ABSTRACT: As a non-invasive treatment technique, HIFU could be used to treat abdominal wall endometriosis.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Abdominal Wall Endometriosis High-Intensity Focused Ultrasound Ablation Muscular Diseases Abdominal Wall Abdominal Wall Adult Adult Endometriosis Endometriosis Female Female High-Intensity Focused Ultrasound Ablation High-Intensity Focused Ultrasound Ablation High-Intensity Focused Ultrasound Ablation Humans Humans Muscular Diseases Muscular Diseases Operative Time

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (19)

Cited by (26)

Source provenance

europepmc
last seen: 2026-10-16T06:09:50.462052+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:20:29.702106+00:00
License: CC0 · commercial use OK